Veterinary Cancer Immunotherapy - Webinar

Free RACE Approved Webinar!

Immunotherapy is revolutionizing human cancer care! Where are we in veterinary oncology? Join us for a free 2-hour, RACE-approved Continuing Education webinar reviewing veterinary cancer immunology and immunotherapy, with an update on ongoing immunotherapy trials at the CSU Flint Animal Cancer Center.

This lecture will review the basics of tumor immunology and immunotherapy, including tumor antigens, innate and adaptive immunity, regulatory T cells and myeloid-derived suppressor cells, and monocyte/macrophage polarization, as well as their relevance to canine cancer immunity. We will then discuss various cancer immunotherapy strategies that have been evaluated in dogs and cats with cancer, as well as “horizon” cancer immunotherapies that may be available soon in animals. These will include tumor vaccines, intralesional gene/immunotherapy approaches, tumor-directed monoclonal antibodies, and the new so-called “immune checkpoint inhibitors”.We will finish with a review of current immunotherapy clinical trials ongoing at the CSU Flint Animal Cancer Center. This webinar qualifies for 2 hours of RACE-approved continuing education.

Douglas H. Thamm, VMD, DACVIM (Oncology)
Dr. Douglas Thamm

Dr. Thamm is the Barbara Cox Anthony Professor of Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. He has authored over 150 peer-reviewed publications and 20 book chapters in veterinary and basic cancer research, is Co-Editor for the most recent edition of  the textbook Withrow and MacEwen’s Small Animal Clinical Oncology, and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology. 

The ENDOSCOPY Talks™ Video Library

A membership is required to access webinar recordings. If you have registered for one or more of the ENDOSCOPY Talks™ you’re already enrolled as a member, log in to access the video content.